Schedule 13G ownership disclosure

TELOMIR PHARMACEUTICALS INC

Common Stock, no par value · CUSIP: 87975F104

Event date: 2025-12-31

Filing-level shares
3,245,000.00
Percent of class
9.438%
  • John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity

    Shares: 3,245,000.00 · Class: 9.438%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-014568
Form type
SCHEDULE 13G/A
Filer
DEJORIA JOHN PAUL
CIK
CIK 897610
Filed
Feb 12, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub